Corporate Investigations

RECENT Corporate Investigations COVERAGE

View all

Health Care Weekly: FDA, Lilly Debate Jurisdiction in Retatrutide Case; Interim Pathway for Wellness Peptide Compounding Mulled; CMS Gains Power to Ban Companies from Government Health Care Programs; Rule Proposed to Implement PBM Reimbursement Law

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Court considers whether Lilly’s challenge to GLP-1 ingredient classification...

Oct 21, 2026 Read Now >
Capitol Forum Analysis of September MAUDE Data

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...

Oct 21, 2026 Read Now >
Maude Monthly: Medline Backlog of Reports Continue to Surge Across Multiple Product Lines; Medline Nitrile Gloves Ripping and Tearing at Increasing Rates; Beta Bionics iLet Exhibiting New Software Malfunction; Insulet Omnipod Leaks and Tears Continue to Climb Months After Recalls

The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...

Oct 21, 2026 Read Now >
Silgan: After Disregarding High Mold and Yeast Results in Manufactured Products, FDA Says Company Should Overhaul Quality System; Expert Says Findings Place Companies at Risk of FDA Withholding Approvals for Product Applications

Silgan Dispensing Systems (SLGN), a contract manufacturer of consumer health care products, didn’t properly investigate or report high mold and yeast counts for drug products made in its Spokane, Washington manufacturing facility, even after an unnamed customer issued a recall due...

Oct 20, 2026 Read Now >
Aquarian/Brighthouse: Filing Says Buyer Seeks to Wipe $2.7 Billion of Losses Off Brighthouse Life’s Books and Create Possible Asset-Management Role for Mubadala Capital; State Regulator Opened Examination of Insurer

Aquarian Capital, which is attempting a $4.1 billion takeover of Brighthouse Financial (BHF), is asking Delaware’s insurance commissioner to let the target’s flagship insurer reset $2.7 billion of accumulated losses to zero as part the acquisition, according to a regulatory filing...

Oct 16, 2026 Read Now >
Financials Friday: Better Markets Calls for Investigation into CFTC Collaboration with Kalshi; Judge Refuses to Toss Consent Order Against Winklevoss Crypto Firm; Bank of America Hit with $1.2 Billion Anti-Money Laundering Fine; Banks Are Liable for What Their AI Chatbots Say; California Expands Regulation of Small Business Lending

Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Better Markets calls for investigation into CFTC’s ties to Kalshi. •...

Oct 16, 2026 Read Now >
Pallone’s Proposal to End IDR Arbitration Could Face Near-Term Challenges, But Signals Growing Pressure to Overhaul No Surprises Act, Sources Say

A proposed law that would scrap a controversial arbitration process associated with the No Surprises Act (NSA) faces an uphill battle when it comes to immediate passage, but the bill comes amid burgeoning bipartisan interest in reforming the NSA that is unlikely to wane in the coming...

Oct 15, 2026 Read Now >
Senators Booker, Warren Urge FTC to Investigate Online Real Estate Market

Senators Cory Booker, D-NJ, and Elizabeth Warren, D-MA, today called on FTC Chairman Andrew Ferguson to open an investigation into allegedly anticompetitive and deceptive practices in the online real estate marketplace. In a letter obtained by The Capitol Forum, Booker and Warren urge...

Oct 15, 2026 Read Now >
EU-China FSR Talks Offer Path to De-Escalation but Raise Fears of Pressure on Enforcement

While the EU’s decision to open formal discussions with China on the application of the Foreign Subsidies Regulation is seen as a potential step towards de-escalation, some experts caution that Beijing could use the talks to secure a softer approach to its...

Oct 15, 2026 Read Now >

What our Customers Say

Barry Nigro

Partner and Antitrust Chair, Fried Frank

"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."
Damien Geradin

Founding Partner, Geradin Partners; Professor of Competition Law and Economics, Tilburg University

“The Capitol Forum’s European coverage stands out for its depth, accuracy, and timeliness. Their investigative reporting and analysis on antitrust, corporate conduct, and regulatory developments offer valuable insights for practitioners and academics alike. As someone deeply engaged in European competition law, I’ve found their work to be consistently thoughtful and impactful.”
Katrina Robson

Partner, Willkie Farr & Gallagher

"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."
Mark Ostrau

Partner, Fenwick & West

"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."

COVERAGE

Investigative coverage of business risks and opportunities

RECENT Corporate Investigations COVERAGE

Health Care Weekly: FDA, Lilly Debate Jurisdiction in Retatrutide Case; Interim Pathway for Wellness Peptide Compounding Mulled; CMS Gains Power to Ban Companies from Government Health Care Programs; Rule Proposed to Implement PBM Reimbursement Law

Capitol Forum Analysis of September MAUDE Data

Maude Monthly: Medline Backlog of Reports Continue to Surge Across Multiple Product Lines; Medline Nitrile Gloves Ripping and Tearing at Increasing Rates; Beta Bionics iLet Exhibiting New Software Malfunction; Insulet Omnipod Leaks and Tears Continue to Climb Months After Recalls

Silgan: After Disregarding High Mold and Yeast Results in Manufactured Products, FDA Says Company Should Overhaul Quality System; Expert Says Findings Place Companies at Risk of FDA Withholding Approvals for Product Applications

Aquarian/Brighthouse: Filing Says Buyer Seeks to Wipe $2.7 Billion of Losses Off Brighthouse Life’s Books and Create Possible Asset-Management Role for Mubadala Capital; State Regulator Opened Examination of Insurer

Pallone’s Proposal to End IDR Arbitration Could Face Near-Term Challenges, But Signals Growing Pressure to Overhaul No Surprises Act, Sources Say

Senators Booker, Warren Urge FTC to Investigate Online Real Estate Market

EU-China FSR Talks Offer Path to De-Escalation but Raise Fears of Pressure on Enforcement

Corporate Investigations Track Record

What our Customers Say

Barry Nigro

Damien Geradin

Katrina Robson

Mark Ostrau

Capitol Forum Subscription